Balkrishna Paper (BALKRISHNA)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 163.08% indicates some revenue momentum, albeit from a very low base.
• Promoter holding at 59.95% aligns promoter interests with minority shareholders to some extent.
• Latest quarterly net profit is ₹-0 Cr, suggesting the company is near breakeven at the operating level.
• 52-week range shows the stock has attracted speculative attention, with price above the ₹12.00 low.

Concerns

• Negative book value of ₹-54.18 per share means the company is technically insolvent on book value basis.
• P/E of 0.00, ROCE of 0.00, and profit growth of -40.56% show no earnings power or return on capital.
• Piotroski F-Score of 3/9 indicates poor financial strength.
• Latest quarterly sales of only ₹2 Cr against a ₹54 Cr market cap makes the valuation reliant on hope, not fundamentals.

AI Analysis

If I look at Balkrishna Paper, the first thing I see is a balance sheet that provides no margin of safety. Book value is negative at ₹-54.18 per share, meaning liabilities exceed assets. That alone would make Benjamin Graham walk away. Price-to-book is not available because there is no positive book value to compare. The P/E of 0.00 and ROCE of 0.00 tell me there are no meaningful earnings or returns on capital. A Piotroski F-Score of 3 out of 9 reinforces a weak financial health picture. Yes, sales growth of 163.08% sounds exciting, but this is from a tiny base; the latest quarter shows sales of only ₹2 Cr and net profit of ₹-0 Cr. So growth is not translating into profit. Profit growth has declined by 40.56%, and the company pays no dividend. At ₹18.75, the market cap is ₹54 Cr, which is small and speculative. Promoter holding of 59.95% is positive, but high ownership does not fix a negative net worth. The 52-week range of ₹12.00 to ₹25.97 shows the stock has moved, but in my framework, this is not an investment. It is a possible turnaround situation requiring proven operational recovery, debt repair, and genuine profitability. I do not buy hope; I buy businesses that generate returns on capital. Until this company proves it can earn consistently and rebuild its equity base, I would remain on the sidelines. In the words of Graham, price is what you pay, value is what you get. Here, the value is deeply uncertain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer